KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Receivables: 2017-2025

Historic Receivables for Elanco Animal Health (ELAN) over the last 7 years, with Sep 2025 value amounting to $975.0 million.

  • Elanco Animal Health's Receivables rose 7.85% to $975.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.0 billion, marking a year-over-year decrease of 1.18%. This contributed to the annual value of $886.0 million for FY2024, which is 12.28% down from last year.
  • Latest data reveals that Elanco Animal Health reported Receivables of $975.0 million as of Q3 2025, which was down 11.60% from $1.1 billion recorded in Q2 2025.
  • Elanco Animal Health's Receivables' 5-year high stood at $1.3 billion during Q1 2023, with a 5-year trough of $886.0 million in Q4 2024.
  • Over the past 3 years, Elanco Animal Health's median Receivables value was $1.1 billion (recorded in 2024), while the average stood at $1.1 billion.
  • As far as peak fluctuations go, Elanco Animal Health's Receivables soared by 90.34% in 2021, and later decreased by 20.35% in 2024.
  • Quarterly analysis of 5 years shows Elanco Animal Health's Receivables stood at $1.0 billion in 2021, then fell by 2.53% to $1.0 billion in 2022, then increased by 0.80% to $1.0 billion in 2023, then decreased by 12.28% to $886.0 million in 2024, then increased by 7.85% to $975.0 million in 2025.
  • Its last three reported values are $975.0 million in Q3 2025, $1.1 billion for Q2 2025, and $1.1 billion during Q1 2025.